IBRX - ImmunityBio, Inc.
9
-1.000 -11.111%
Share volume: 32,792,651
Last Updated: 03-04-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.44%
PREVIOUS CLOSE
CHG
CHG%
$10.00
0.00
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-09-2024 | 08-12-2024 | 11-12-2024 | 03-03-2025 | 05-12-2025 | 08-05-2025 | 11-05-2025 | 02-23-2026 | |
| Total revenue | 40.000 K | 1.047 M | 6.106 M | 7.552 M | 16.517 M | 0.000 | 32.061 M | 64.710 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 58.000 K | 272.000 K | 354.000 K | 69.000 K | |
| Gross profit | 40.000 K | 1.047 M | 6.106 M | 7.552 M | 16.459 M | -272.000 K | 31.707 M | 64.641 M | |
| 2,517.50% | 483.19% | 23.68% | 117.94% | -101.65% | 11,756.99% | 103.87% | |||
| Operating expenses | 95.236 M | 100.380 M | 86.359 M | 76.952 M | 80.888 M | 195.148 M | 175.028 M | -82.502 M | |
| Selling general and admin | 41.885 M | 49.251 M | 35.916 M | 41.731 M | 32.654 M | 84.676 M | 72.564 M | -39.891 M | |
| Research and development | 53.351 M | 51.129 M | 50.443 M | 35.221 M | 48.234 M | 110.472 M | 102.464 M | -42.611 M | |
| Total expenses | 95.236 M | 100.380 M | 86.359 M | 76.952 M | 80.888 M | 195.148 M | 175.028 M | -82.502 M | |
| 5.40% | -13.97% | -10.89% | 5.11% | 141.26% | -10.31% | -147.14% | |||
| Operating income | -95.196 M | -99.333 M | -80.253 M | -69.400 M | -64.429 M | -142.570 M | -111.260 M | 62.232 M | |
| Ebit | -99.742 M | -97.456 M | -47.303 M | -22.792 M | -101.922 M | -129.148 M | -81.246 M | 66.829 M | |
| Pretax income | -134.130 M | -134.584 M | -85.752 M | -59.179 M | -129.900 M | -184.610 M | -134.618 M | 97.521 M | |
| 0.34% | -36.28% | -30.99% | 119.50% | 42.12% | -27.08% | -172.44% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | -234.000 K | 538.000 K | -35.000 K | -404.000 K | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -134.130 M | -134.584 M | -85.752 M | -59.179 M | -129.666 M | -185.148 M | -134.548 M | 97.890 M | |
| -0.34% | 36.28% | 30.99% | -119.11% | -42.79% | 27.33% | 172.75% |